Tokyo, Japan

Anqi Tao

This inventor holds 3 USPTO granted patents. Top assignee: The University of Tokyo. Active years: 2026.


% Patents Active = 33.3

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anqi Tao: Innovator in Drug Delivery Systems

Introduction

Anqi Tao is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. Her innovative work focuses on enhancing the efficacy of drug delivery while minimizing potential side effects.

Latest Patents

One of her latest patents is titled "Delivery of cyclic compound by using carrier." This invention describes a drug delivery system that effectively delivers a cyclic compound to a target cell or tissue while suppressing the pharmacological activity of the compound. The system includes a complex that consists of the cyclic compound and a delivery carrier, which features a shaft portion designed to carry the cyclic compound. This shaft portion is complexed by inclusion in the cyclic compound, forming a host-guest complex.

Another notable patent is the "Protein-enclosing polymeric micelle." This invention provides a polymeric complex that comprises a protein and a block copolymer, represented by a specific formula. This innovative approach aims to improve the stability and delivery of therapeutic proteins.

Career Highlights

Anqi Tao is affiliated with The University of Tokyo, where she continues to advance her research in drug delivery technologies. Her work has garnered attention for its potential applications in various medical fields, particularly in targeted therapies.

Collaborations

Anqi has collaborated with esteemed colleagues, including Horacio Cabral and Takuya Miyazaki. These collaborations have further enriched her research and contributed to the development of her innovative patents.

Conclusion

Anqi Tao is a trailblazer in the realm of drug delivery systems, with a focus on cyclic compounds and polymeric micelles. Her contributions are paving the way for advancements in targeted therapies, showcasing her dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…